Approval · Notice of Compliance 27010 · 2021
SALOFALK: Notice of Compliance 27010
Issued November 10, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27010
- Date
- November 10, 2021
- Company
- Aptalis Pharma Canada UlcMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety Updates to the Product Monograph (PM) and updated the PM to the 2020 Master Template.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SALOFALK | Not yet assigned | — |
Medicinal ingredients
- MESALAZINE 500 MG per TAB